Mckesson Corp (MCK)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

1 - 10
Next >>

McKesson Corporation (MCK) Surged Following a Decent Set of Results

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

June 18th, 2025 - Hedge Fund Investor Letters News

Morgan Stanley Hikes McKesson (MCK) Price Target on Earnings Growth Prospects

McKesson Corporation (NYSE:MCK) is one of the 12 best healthcare stocks to buy now.

Keep Reading →

June 17th, 2025 - News

12 Best Healthcare Stocks to Buy Now

Healthcare companies in the US are facing policy headwinds under President Donald Trump's Administration.

Keep Reading →

June 16th, 2025 - Hedge Funds News

Wells Fargo Affirms McKesson (MCK) Equal Weight Rating and $766 Price Target

McKesson Corporation (NYSE:MCK) is one of the best 52-week high stocks to buy, according to analysts. On June 10, Wells Fargo reiterated an Equal Weight on the stock and a $766 price target.

Keep Reading →

June 16th, 2025 - News

Leerink Partners Remains Bullish on McKesson Corporation (MCK), Retains a $785 Price Target

McKesson Corporation (NYSE:MCK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, analyst Michael Cherny of Leerink Partners maintained a Buy rating on McKesson Corporation...

Keep Reading →

June 15th, 2025 - News

11 Best Drug Stocks to Buy According to Hedge Funds

Health and Human Services Secretary Robert F. Kennedy Jr.

Keep Reading →

June 13th, 2025 - News

10 Best 52-Week High Stocks to Buy According to Analysts

Volatility in the equity markets under President Donald Trump has already hit record highs. Amid the heightened volatility, US equities have also bounced back on optimism about US-China trade negotiations...

Keep Reading →

June 12th, 2025 - Hedge Funds News

Wells Fargo Raises McKesson (MCK) Price Target, Maintains Equal Weight Rating

Wells Fargo raised its price target on McKesson Corporation (NYSE:MCK) to $766 from $691, on June 3, while maintaining an Equal Weight rating, following the company’s fourth-quarter earnings report ...

Keep Reading →

June 4th, 2025 - News

McKesson Corporation (MCK) Finalizes Purchase of Core Ventures

McKesson Corporation (NYSE:MCK) announced that it has finalized the purchase of a majority stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative...

Keep Reading →

June 3rd, 2025 - News